Protein CK5 a Marker for Cisplatin-Resistant Ovarian Cancer

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

A University of Colorado Cancer Center study recently published by Corr et al in the International Journal of Gynecological Cancer1 shows that protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in breast cancer, also marks ovarian cancers likely to be resistant to the common chem...